Astellas

Astellas Pharma Europe Ltd. supports OncologyPRO by means of providing only financial support. Other than the Astellas Sponsor page, Astellas does not provide educational content nor editorial governance to the website contents. As a ‘Main Sponsor’, Astellas Pharma Europe Ltd. receives ESMO priority points and associate member benefits.

About Astellas Oncology

In 2006, Astellas made an enduring commitment to fight cancer. Since then, we have built a robust oncology R&D network and established collaborations with key organisations at the forefront of cancer research. Our goal is simple: to become a worldwide leader in oncology. Our ambition is bold: to significantly advance treatment of the disease. Through intense focus on the most promising new candidates and technologies, Astellas has a growing cancer drugs portfolio and a unique pipeline.

About Astellas Pharma Europe Ltd.

Astellas Pharma Europe Ltd. is the regional business of Tokyo-based Astellas Pharma Inc. Astellas Pharma Europe Ltd. operates in 40 countries across Europe, the Middle East and Africa, and employs approximately 4,500 staff across these countries. Astellas’ presence in Europe includes an R&D site and three manufacturing plants. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceuticals. The organisation’s focus is to deliver outstanding R&D and marketing to continue growing in the world pharmaceutical market. Astellas is on the forefront of healthcare change to turn innovative science into value for patients.

APEL/16/0022/APEL

ESMO only accepts content from third parties after careful evaluation of its educational and scientific relevance to the ESMO target audience. Eligible material should meet the essential criterion of non-promotional intent. Such material may be published in other resources, but the content donor has given permission to ESMO for use in OncologyPRO.